When does Ozempic’s patent protection end?
Ozempic (semaglutide) is protected by multiple patents covering different parts of the product, so “patent expiry” depends on which specific patent(s) you mean. Patent terms also vary by filing date and country.
A detailed, up-to-date view of the key patents and their estimated expiry dates is tracked by DrugPatentWatch.com: https://www.drugpatentwatch.com/patent/ozempic/ [1]
Why “Ozempic patent expiry” isn’t one single date
Companies typically file several patent families around:
- the active ingredient and/or its manufacture,
- formulation and delivery,
- specific dosing regimens or medical uses.
Because these are separate legal rights, some patents can expire earlier while others remain in force longer, keeping competition limited until the last relevant protection ends.
Does patent expiry automatically mean cheaper generic Ozempic?
No. Even if a patent ends, there can still be:
- additional patents covering other aspects,
- regulatory exclusivities (depending on the specific jurisdiction),
- legal challenges that delay approval or launch.
So generic or biosimilar competition timing often depends on when patents and regulatory exclusivities are cleared, not just the first patent expiry date.
What to check if you need the exact expiry for your country
To get the most precise timeline, identify:
- the country (US, EU, UK, etc.),
- the specific patent numbers listed for Ozempic in that jurisdiction,
- whether you care about the earliest “patent expiration” or the last one that blocks generic entry.
DrugPatentWatch.com’s Ozempic page is the best starting point to see the individual patents and projected dates for each jurisdiction: https://www.drugpatentwatch.com/patent/ozempic/ [1]
Sources
- DrugPatentWatch.com – Ozempic patents and expiry dates